AID GENOMICS

Established in 2018, AID Genomics is engaged in developing molecular diagnostics for personalized therapeutic approaches in oncology, genetics, and virology. Founding members include Kelvin Wu (our Chairman), Snir Zano (our CEO), and Dr. Izhak Haviv (our Chief Scientific Officer). Also in 2018, AID Genomics acquired Rosetta microRNA patents, for the development of microRNA-based tests to detect, diagnose and provide treatments for various malignancies... AID Genomics is an international group of medical technology companies specialized in the diagnosis and therapy of cancer and infectious diseases like COVID-19. AID Genomics' advanced testing platforms were developed by a leading team of experts in oncology, molecular biology, molecular pathology, genomics and bioinformatics... We are a research and development-driven diagnostic company focused on the development of precision medicine-based diagnostic solutions primarily for oncology but also for hereditary rare diseases and..

Primary location: Los Angeles United States